{"id":"https://openalex.org/W4389727341","doi":"https://doi.org/10.1080/1061186x.2023.2295803","title":"A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches","display_name":"A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches","alternate_titles":[],"publication_year":2023,"publication_date":"2023-12-14","ids":{"openalex":"https://openalex.org/W4389727341","doi":"https://doi.org/10.1080/1061186x.2023.2295803","pmid":"https://pubmed.ncbi.nlm.nih.gov/38096045"},"language":"en","primary_location":{"id":"doi:10.1080/1061186x.2023.2295803","doi":"https://doi.org/10.1080/1061186x.2023.2295803","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1061186x.2023.2295803","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4389727341"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043885224","display_name":"Anmar Al\u2010Taie","orcid":"https://orcid.org/0000-0002-2183-6830","observed_orcids":["https://orcid.org/0000-0002-2183-6830"]},"institutions":[{"id":"https://openalex.org/I4210121333","display_name":"Istinye University","ror":"https://ror.org/03081nz23","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210121333"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Anmar Al-Taie","raw_affiliation_strings":["Clinical Pharmacy Department, Faculty of Pharmacy, Istinye University, Istanbul, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0002-2183-6830","affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Faculty of Pharmacy, Istinye University, Istanbul, T\u00fcrkiye","institution_ids":["https://openalex.org/I4210121333"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024035848","display_name":"Ece \u00d6zcan B\u00fclb\u00fcl","orcid":"https://orcid.org/0000-0001-7112-923X","observed_orcids":["https://orcid.org/0000-0001-7112-923X"]},"institutions":[{"id":"https://openalex.org/I4210121333","display_name":"Istinye University","ror":"https://ror.org/03081nz23","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210121333"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ece \u00d6zcan B\u00fclb\u00fcl","raw_affiliation_strings":["Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0001-7112-923X","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul, T\u00fcrkiye","institution_ids":["https://openalex.org/I4210121333"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5043885224"],"corresponding_institution_ids":["https://openalex.org/I4210121333"],"apc_list":null,"apc_paid":null,"fwci":0.3143,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.2675934,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"32","issue":"1","first_page":"45","last_page":"56"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9950000047683716},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6909999847412109},{"id":"https://openalex.org/keywords/antibody-conjugated-nanoparticles","display_name":"antibody-conjugated nanoparticles","score":0.878000020980835},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7749999761581421},{"id":"https://openalex.org/keywords/polymeric-nanoparticles","display_name":"polymeric nanoparticles","score":0.8560000061988831},{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.9480000138282776},{"id":"https://openalex.org/keywords/inorganic-nanoparticles","display_name":"inorganic nanoparticles","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.796999990940094},{"id":"https://openalex.org/keywords/antibody-classification","display_name":"antibody classification","score":0.5950000286102295},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.3319999873638153}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7462040185928345},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6255828142166138},{"id":"https://openalex.org/C112613896","wikidata":"https://www.wikidata.org/wiki/Q898370","display_name":"Conjugated system","level":3,"score":0.6053537130355835},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4854191243648529},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4647231698036194},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4542473256587982},{"id":"https://openalex.org/C148043351","wikidata":"https://www.wikidata.org/wiki/Q4456944","display_name":"Current (fluid)","level":2,"score":0.44212812185287476},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35288965702056885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31802332401275635},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24324512481689453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23837286233901978},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.07529285550117493},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/1061186x.2023.2295803","doi":"https://doi.org/10.1080/1061186x.2023.2295803","is_oa":false,"landing_page_url":"https://doi.org/10.1080/1061186x.2023.2295803","pdf_url":null,"source":{"id":"https://openalex.org/S100629371","display_name":"Journal of drug targeting","issn_l":"1026-7158","issn":["1026-7158","1029-2330","1061-186X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Targeting","raw_type":"journal-article"},{"id":"pmid:38096045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38096045","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drug targeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":85,"referenced_works":["https://openalex.org/W957165159","https://openalex.org/W1533841403","https://openalex.org/W1758612015","https://openalex.org/W1973031611","https://openalex.org/W2002787729","https://openalex.org/W2043228552","https://openalex.org/W2044626782","https://openalex.org/W2049408139","https://openalex.org/W2059050919","https://openalex.org/W2066936530","https://openalex.org/W2078562507","https://openalex.org/W2081641593","https://openalex.org/W2086231349","https://openalex.org/W2089276240","https://openalex.org/W2108422551","https://openalex.org/W2119812267","https://openalex.org/W2129423585","https://openalex.org/W2140738105","https://openalex.org/W2142351635","https://openalex.org/W2155284019","https://openalex.org/W2164353181","https://openalex.org/W2169852145","https://openalex.org/W2201172943","https://openalex.org/W2255353486","https://openalex.org/W2379702652","https://openalex.org/W2546940349","https://openalex.org/W2589368196","https://openalex.org/W2605865028","https://openalex.org/W2606902890","https://openalex.org/W2619806309","https://openalex.org/W2728093281","https://openalex.org/W2745392353","https://openalex.org/W2761040900","https://openalex.org/W2784605149","https://openalex.org/W2791123071","https://openalex.org/W2806708871","https://openalex.org/W2808910312","https://openalex.org/W2896316027","https://openalex.org/W2900062640","https://openalex.org/W2901219686","https://openalex.org/W2901451421","https://openalex.org/W2905439462","https://openalex.org/W2909543600","https://openalex.org/W2917351875","https://openalex.org/W2938140328","https://openalex.org/W2942911318","https://openalex.org/W2944833659","https://openalex.org/W2955284395","https://openalex.org/W2969908486","https://openalex.org/W2970994214","https://openalex.org/W2971940586","https://openalex.org/W2994597968","https://openalex.org/W2996211630","https://openalex.org/W3001632525","https://openalex.org/W3007332019","https://openalex.org/W3008784107","https://openalex.org/W3017040627","https://openalex.org/W3042291772","https://openalex.org/W3044690826","https://openalex.org/W3113491846","https://openalex.org/W3116959242","https://openalex.org/W3121452472","https://openalex.org/W3130720760","https://openalex.org/W3157163377","https://openalex.org/W3164121144","https://openalex.org/W3171081002","https://openalex.org/W4210534116","https://openalex.org/W4211226234","https://openalex.org/W4220823988","https://openalex.org/W4220847494","https://openalex.org/W4220988523","https://openalex.org/W4224771916","https://openalex.org/W4238637390","https://openalex.org/W4282031654","https://openalex.org/W4284676157","https://openalex.org/W4295517237","https://openalex.org/W4300981846","https://openalex.org/W4307235773","https://openalex.org/W4310724607","https://openalex.org/W4311401290","https://openalex.org/W4311439475","https://openalex.org/W4317754109","https://openalex.org/W4318561812","https://openalex.org/W4327609524","https://openalex.org/W4388339835"],"related_works":["https://openalex.org/W7086975929","https://openalex.org/W4311258919","https://openalex.org/W3081139136","https://openalex.org/W3081160019","https://openalex.org/W4251008670","https://openalex.org/W4385406118","https://openalex.org/W3135200830","https://openalex.org/W2600609026","https://openalex.org/W4405096930","https://openalex.org/W2081385214"],"abstract_inverted_index":{"Monoclonal":[0],"antibodies":[1],"(mAbs)":[2],"are":[3,93,111,175],"integral":[4],"to":[5,154],"cancer":[6,46,151,156],"treatment":[7,131,152,170,192],"over":[8],"conventional":[9],"non-specific":[10],"therapy":[11],"methods.":[12],"This":[13],"study":[14],"provides":[15],"a":[16,94],"scoping":[17],"review":[18],"of":[19,29,64,75,96,103,115,161,171,193],"the":[20,26,56,148,159,169],"clinically":[21],"approved":[22],"mAbs,":[23],"focusing":[24],"on":[25],"current":[27],"application":[28],"different":[30,113],"nanocarrier":[31],"technologies":[32],"as":[33,41,173,179],"drug":[34,183],"delivery":[35,160,184],"targets":[36],"for":[37,44,129,190],"mAb-conjugated":[38,97],"nanoparticles":[39],"(NPs)":[40],"potential":[42],"features":[43],"breast":[45],"(BC)":[47],"treatment.":[48],"An":[49],"extensive":[50],"literature":[51],"search":[52],"was":[53],"conducted":[54],"between":[55],"years":[57],"2000":[58],"and":[59,73,78,89,122,139,181],"2023":[60],"using":[61],"various":[62,136],"sources":[63],"databases.":[65],"The":[66,83],"first":[67],"part":[68,85],"covered":[69,86],"mAb":[70],"classification,":[71],"types,":[72],"mechanisms":[74],"action,":[76],"pharmacokinetics":[77],"clinical":[79],"applications":[80],"in":[81,150,168],"BC.":[82,100,194],"second":[84],"polymeric,":[87],"lipid":[88],"inorganic-based":[90],"NPs,":[91,119],"which":[92],"variety":[95],"NPs":[98,121,174],"targeting":[99,155],"A":[101],"total":[102],"20":[104],"relevant":[105],"studies":[106],"were":[107],"enrolled":[108],"indicating":[109],"there":[110],"three":[112],"types":[114],"nanoparticular":[116],"systems":[117,165],"(polymeric":[118],"inorganic":[120],"lipid-based":[123],"NPs)":[124],"that":[125,186],"can":[126,187],"be":[127,188],"used":[128],"BC":[130],"by":[132],"being":[133,177],"loaded":[134],"with":[135,141,163],"active":[137],"substances":[138],"conjugated":[140],"these":[142],"antibodies.":[143],"While":[144],"mAbs":[145,162],"have":[146],"altered":[147],"way":[149],"due":[153],"cells":[157],"specifically,":[158],"nanoparticulate":[164],"is":[166],"important":[167],"BC,":[172],"still":[176],"investigated":[178],"distinctive":[180],"promising":[182],"methods":[185],"employed":[189],"effective":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4389727341","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2023-12-15T00:00:00"}
